JP2023514371A5 - - Google Patents
Info
- Publication number
- JP2023514371A5 JP2023514371A5 JP2022549653A JP2022549653A JP2023514371A5 JP 2023514371 A5 JP2023514371 A5 JP 2023514371A5 JP 2022549653 A JP2022549653 A JP 2022549653A JP 2022549653 A JP2022549653 A JP 2022549653A JP 2023514371 A5 JP2023514371 A5 JP 2023514371A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- polypeptide
- light chain
- chain polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026017499A JP2026086568A (ja) | 2020-02-19 | 2026-02-05 | 操作された抗her2二重特異性タンパク質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062978758P | 2020-02-19 | 2020-02-19 | |
| US62/978,758 | 2020-02-19 | ||
| PCT/US2021/018705 WO2021168194A1 (en) | 2020-02-19 | 2021-02-19 | Engineered anti-her2 bispecific proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026017499A Division JP2026086568A (ja) | 2020-02-19 | 2026-02-05 | 操作された抗her2二重特異性タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023514371A JP2023514371A (ja) | 2023-04-05 |
| JP2023514371A5 true JP2023514371A5 (cg-RX-API-DMAC7.html) | 2024-02-26 |
Family
ID=77391704
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549653A Pending JP2023514371A (ja) | 2020-02-19 | 2021-02-19 | 操作された抗her2二重特異性タンパク質 |
| JP2026017499A Pending JP2026086568A (ja) | 2020-02-19 | 2026-02-05 | 操作された抗her2二重特異性タンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026017499A Pending JP2026086568A (ja) | 2020-02-19 | 2026-02-05 | 操作された抗her2二重特異性タンパク質 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230192887A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4181950A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023514371A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220156526A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115361972A (cg-RX-API-DMAC7.html) |
| AR (1) | AR121384A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021224200A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022016232A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3170338A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL295729A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022010161A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202144431A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021168194A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS63818B1 (sr) | 2017-02-17 | 2023-01-31 | Denali Therapeutics Inc | Konstruisani polipeptidi za vezivanje za receptor transferina |
| JP7543290B2 (ja) | 2019-02-20 | 2024-09-02 | デナリ セラピューティクス インコーポレイテッド | 抗trem2抗体及びその使用方法 |
| CR20230178A (es) | 2020-10-14 | 2023-07-26 | Denali Therapeutics Inc | Proteínas de fusión que comprenden enzimas sulfoglucosamina sulfohidrolasa y métodos de estas |
| IL311003A (en) | 2021-08-25 | 2024-04-01 | Denali Therapeutics Inc | Anti-2HER antibodies and methods of using them |
| US20240392035A1 (en) * | 2021-08-25 | 2024-11-28 | Denali Therapeutics Inc. | Engineered anti-her2 bispecific proteins |
| CN120077064A (zh) * | 2022-08-05 | 2025-05-30 | 詹森生物科技公司 | 用于治疗脑肿瘤的转铁蛋白受体结合蛋白 |
| EP4565331A1 (en) * | 2022-08-05 | 2025-06-11 | Janssen Biotech, Inc. | Cd98 binding constructs for treating brain tumors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005047327A2 (en) * | 2003-11-12 | 2005-05-26 | Biogen Idec Ma Inc. | NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
| US9101674B2 (en) * | 2010-03-29 | 2015-08-11 | Vib Vzw | Targeting and in vivo imaging of tumor-associated macrophages |
| LT3074424T (lt) * | 2013-11-27 | 2025-05-26 | Zymeworks Bc Inc. | Bispecifiniai antigeną surišantys konstruktai, nukreipti į her2 |
| WO2015095412A1 (en) * | 2013-12-19 | 2015-06-25 | Zhong Wang | Bispecific antibody with two single-domain antigen-binding fragments |
| JP6510532B2 (ja) * | 2013-12-20 | 2019-05-08 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 二重特異性her2抗体及び使用方法 |
| CA2943299A1 (en) * | 2014-04-11 | 2015-10-15 | Medimmune, Llc | Bispecific her2 antibodies |
| US10717783B2 (en) * | 2014-12-22 | 2020-07-21 | Zeren Gao | Bispecific tetravalent antibodies and methods of making and using thereof |
| JP7021955B2 (ja) * | 2015-06-24 | 2022-03-03 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | Her2及び血液脳関門受容体に特異的な三重特異性抗体及び使用方法 |
| CA3053381A1 (en) * | 2017-02-17 | 2018-08-23 | Denali Therapeutics Inc. | Engineered polypeptides |
| WO2019032955A1 (en) * | 2017-08-10 | 2019-02-14 | Denali Therapeutics Inc. | MODIFIED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES |
| RU2018111298A (ru) * | 2018-03-29 | 2019-10-01 | Закрытое Акционерное Общество "Биокад" | Биспецифическое антитело, которое специфично связывается с IV и II cубдоменами внеклеточного домена HER2 человека |
| EP3840781A1 (en) * | 2018-08-22 | 2021-06-30 | Denali Therapeutics Inc. | Anti-her2 polypeptides and methods of use thereof |
-
2021
- 2021-02-19 CA CA3170338A patent/CA3170338A1/en active Pending
- 2021-02-19 AU AU2021224200A patent/AU2021224200A1/en not_active Abandoned
- 2021-02-19 AR ARP210100440A patent/AR121384A1/es unknown
- 2021-02-19 MX MX2022010161A patent/MX2022010161A/es unknown
- 2021-02-19 EP EP21756590.2A patent/EP4181950A4/en active Pending
- 2021-02-19 IL IL295729A patent/IL295729A/en unknown
- 2021-02-19 WO PCT/US2021/018705 patent/WO2021168194A1/en not_active Ceased
- 2021-02-19 TW TW110105842A patent/TW202144431A/zh unknown
- 2021-02-19 KR KR1020227028989A patent/KR20220156526A/ko not_active Ceased
- 2021-02-19 BR BR112022016232A patent/BR112022016232A2/pt unknown
- 2021-02-19 CN CN202180027050.7A patent/CN115361972A/zh active Pending
- 2021-02-19 JP JP2022549653A patent/JP2023514371A/ja active Pending
-
2022
- 2022-08-11 US US17/819,182 patent/US20230192887A1/en active Pending
-
2026
- 2026-02-05 JP JP2026017499A patent/JP2026086568A/ja active Pending